Noradrenalin Kalceks (Norepinephrine)

Noradrenalin Kalceks is a vasopressor that acts on the adrenergic system to support circulatory function in critical care settings.

• Hypotension: restores adequate arterial pressure and organ perfusion.
• Septic shock: counteracts vasodilatory failure to maintain hemodynamic stability.
• Cardiac arrest: provides immediate pressor support during resuscitation efforts.

• Norepinephrine binds directly to α1‑adrenergic receptors on vascular smooth muscle, causing potent vasoconstriction, and to β1‑adrenergic receptors in the heart, increasing contractility and heart rate. The combined α‑ and β‑adrenergic stimulation raises systemic vascular resistance and cardiac output, thereby elevating mean arterial pressure in patients with circulatory collapse. Its rapid onset after intravenous administration makes it suitable for acute management of life‑threatening hypotension.

Norepinephrine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Tachycardia: increased heart rate.
• Headache: mild to moderate intensity.
• Anxiety or restlessness.
• Peripheral vasoconstriction causing cold extremities.
• Hypertension: excessive rise in blood pressure.

Serious or Rare Side Effects

• Cardiac arrhythmias: potentially life‑threatening rhythm disturbances.
• Myocardial ischemia: reduced coronary blood flow.
• Tissue necrosis at extravasation sites.
• Severe hypertension leading to stroke.
• Pulmonary edema: fluid accumulation in the lungs.

When using Noradrenalin Kalceks, clinicians should observe several safety measures to minimize risks.

• Blood pressure monitoring: continuously assess arterial pressure to titrate dose.
• Cardiac rhythm surveillance: watch for arrhythmias or ischemic changes.
• Dose titration: adjust infusion slowly based on response.
• Extravasation risk: avoid infiltration; stop infusion immediately if leakage occurs.
• Caution in myocardial ischemia: use only if benefits outweigh risks.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other agents, altering its pressor effect or increasing adverse events.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis.
• Indirect sympathomimetics (e.g., ephedrine): additive vasoconstriction risk.
• Tricyclic antidepressants: potentiate pressor response.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt β1 effects, requiring higher norepinephrine doses.
• Calcium channel blockers: can enhance hypotensive episodes if norepinephrine is reduced.
• Other vasopressors (e.g., phenylephrine): may lead to excessive vasoconstriction.
• ACE inhibitors: may diminish pressor response, necessitating dose adjustments.